References
Akinci B, Sahinoz M, Oral E (2018) Lipodystrophy Syndromes: Presentation and Treatment. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar R, Singer F, Trence DL, Vinik A, Wilson DP, editors. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2000; https://www.ncbi.nlm.nih.gov/books/NBK513130/
Akinci B, Meral R, Oral E (2018) Phenotypic and genetic characteristics of lipodystrophy: pathophysiology, metabolic abnormalities, and comorbidities. Curr Diab Rep 18:143. https://doi.org/10.1007/s11892-018-1099-9
Hussaina I, Gargba A (2008) Lipodystrophy syndromes. Dermatol Clin 26(4):569–578
Lightbourne M, Brown RJ (2017) Genetics of lipodystrophy. Endocrinol Metab Clin North Am 46(2):539–554
Ceccarini G, Magno S, Pelosini C et al (2020) Congenital generalized lipoatrophy (Berardinelli-Seip Syndrome) Type 1: description of novel AGPAT2 homozygous variants showing the highly heterogeneous presentation of the disease. Front Endocrinol (Lausanne) 11:39. https://doi.org/10.3389/fendo.2020.00039
Funding
This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Availability of data and material
The data generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Ethical approval
This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the University Hospital of Endocrinology.
Informed consent
Informed consent was obtained from the patient including a separate informed consent for the genetic analysis and consent for publication of this case report and accompanying images.
Additional information
Managed by Massimo Federici.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Chakarova, N., Balabanski, L., Dimova, R. et al. A novel AGPAT2 mutation associated with a case of late-diagnosed congenital generalized lipodystrophy type 1. Acta Diabetol 58, 505–511 (2021). https://doi.org/10.1007/s00592-020-01639-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00592-020-01639-w